Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6103879

Title:Bivalent molecules that form an activating complex with an erythropoietin receptor
Inventors:Chaovapong, Warak Lee; San Diego, CA, USA
Giebel, Lutz B.; San Mateo, CA, USA
Karkaria, Cyrus; Cambridge, MA, USA
Ross, Michael J.; San Mateo, CA, USA
Schneider, Helmut H.; San Francisco, CA, USA
Shoemaker, Kevin; San Francisco, CA, USA
Summary:Described herein are novel monoclonal antibodies and bivalent molecules which activate erythropoietins and induce the proliferation or differentiation of erythroid progenitor cells. Further disclosed are hybridoma cell lines and associated pharmaceutical compositions. Therapeutic and experimental applications are included, such as in drug development and in the treatment and diagnosis of conditions due to diminished erythropoietin receptor activity such as anemia.
Abstract:
US Patent Website:Click Here for Full Text of Patent
Title Number:US6103879
Application Number:US1997000876813
Date Filed:16/06/1997
Date Published:15/08/2000
Assignee:Axys Pharmaceuticals, Inc., South San Francisco, CA, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/22/2021